Richard Byrd Pollard, M.D.
Philosophy of Care
My philosophy of care is comprehensive primary care of HIV-infected patients and patients with
other infectious diseases.
Clinical Interests
Dr. Pollard’s clinical research includes usage of new antiviral drugs, the care of HIV-infected
patients, HIV vaccines as well as clinical immunology. Pollard’s research interests include
immunology of viral infections, immune responses to HIV, CMV, HPV, and VZV as well as
immunologic non-responders.
Title
Specialty
Department
Division
Center/Program Affiliation
Address/Phone
Professor
Infectious Diseases, Internal Medicine
Internal Medicine
Infectious Diseases
Northern California Center for AIDS Research
CARES Clinic, 1500 21st St. Sacramento, CA 95817
Phone: 800-2-UCDAVIS
Patient Support Services Building, 4150 V Street Suite G500 Sacramento, CA 95817
Additional Phone
Phone: 916-734-3815
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
Education
M.D., University of Maryland School of Medicine, Baltimore, Maryland, 1970
Internships
Ohio State University, Columbus, Ohio, 1970-71
Residency
Emory University , Atlanta, Georgia, 1973-75
Fellowships
Board Certifications
Professional Memberships
Stanford University Medical Center, Stanford, California, 1975-78
American Board of Internal Medicine, 1975
American Association of Immunologists
American College of Physicians, Fellow
Infectious Diseases Society of America, Fellow
Sigma Xi
Richard Byrd Pollard, M.D.
Honors and Awards
Best Doctors in America, 2010
Best Doctors in America, 2009
Best Doctors in America, 2007
Select Recent Publications
Rodriguez B, Asmuth DM, Matining RM, Spritzler J, Jacobson JM, Mailliard RB, Li XD, Martinez AI,
Tenorio AR, Lori F, Lisziewicz J, Yesmin S, Rinaldo CR, and Pollard RB. Safety, tolerability, and
immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIVinfected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.
JAIDS, 2013;64(4): 351-359.
Nagy LH, Grishina I, Macal M, Hirao LA, Hu WK, Sankaran- Walters S, Gaulke CA, Pollard RB,
Brown J, Suni M, Baumler AJ, Ghanekar S, Marco ML, Dandekar S. Chronic HIV infection
enhances the responsiveness of antigen presenting cells to commensal lactobacillus. PLoS ONE,
2013;8(8): e72789.
Kalayjian RC, Spritzler J, Matining RM, Fiscus SA, Gross BH, Francis IR, Pollard RB, Lederman
MM, and Landay A. Older HIVinfected patients on antiretroviral therapy have B-cell expansion and
attenuated CD4 cell increases with immune activation reduction. AIDS, 2013; 27(10): 1563-1571.
Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li XD, Dotterweich W, Pollard RB, Asmuth DM,
Berglund L. HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein
(a) levels. Arteriosclerosis, Thrombosis, and Vascular Biology, 2013;33(2): 387-392.
Allen ME, Brown J, Karakas SE, and Pollard RB. Refractory AIDS cholangiopathy: metabolic
complications and the role of plasmapheresis. AIDS, 2013;27(7): 1193–1194.
Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks S,
Shacklett BL. HIV+ Viremic Slow Progressors Maintain Low Regulatory T-Cell Numbers in Rectal
Richard Byrd Pollard, M.D.
Mucosa but Exhibit High T-cell Activation. AIDS Research and Human Retroviruses, 2013;29(1):
172-177.
Hulgan t, Robbins GK, Kalams SA, Samuels DC, Grady B, Shafer R, Murdock DG, Selph D, Haas
DW, Pollard RB for the AIDS Clinical Trials Group. T Cell Activation Markers and African
Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials
Group Study 384. PLoS One, 2012;7(8): e43803.
Hayes TL, Asmuth DM, Critchfield JW, Knight TH, McLaughlin BE, Yotter T, McConnell DH,
Garcia JC, Pollard RB, Shacklett BL. Impact of highly active antiretroviral therapy initiation on
CD4+ T-cell repopulation in duodenal and rectal mucosa. AIDS, 2012;27: 867-877.
Pollard RB, Rockstroh JK, Pantaleo G, Asmuth DM, Peters B,Lazzarin A, Garcia F, Ellefsen K,
Podzamczer D, van Lunzen J, Arastéh K, Schürmann D, Clotet B, Hardy WD, Mitsuyasu R,
MoyleG, Plettenberg A, Fisher M, Fätkenheuer G, Fischl M, Taiwo B,Baksaas I, Jolliffe D, Persson S,
Jelmert O, Hovden AO, SommerfeltMA, Wendel-Hansen V, and Sørensen B. Safety and efficacy of
thepeptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind,
placebo-controlled trial. The Lancet, 2014;14(4):291-300.
Brown J, Burger H, Weiser B, Pollard RB, Li XD, Clancy LJ, Baumann R, Rogers A, Hamdan HB,
Pesana RL, and Kagan RM. A genotypic HIV-1 proviral DNA coreceptor tropism assay:
characterization in viremic subjects. AIDS Research and Therapy, 2014;11(14): 1-7.
© 2016 UC Regents